tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Income Statement

Compare
822 Followers

Gyre Therapeutics Income Statement

Last quarter (Q3 2025), Gyre Therapeutics's total revenue was $30.56M, an increase of 19.92% from the same quarter last year. In Q3, Gyre Therapeutics's net income was $3.61M. See Gyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 105.76M$ 113.45M$ 102.29M$ 7.34M$ 20.95M
Gross Profit
$ 101.87M$ 108.81M$ 97.50M$ -332.00K$ 11.79M
Operating Expenses
$ 85.71M$ 176.04M$ 88.29M$ 83.39M$ 69.16M
Depreciation and Amortization
$ 1.59M$ 1.11M$ 1.13M$ 290.00K$ 138.00K
EBITDA
$ 17.82M$ 20.33M$ 10.33M$ -87.64M$ -56.10M
Operating Income
$ 16.16M$ -67.23M$ 9.20M$ -83.73M$ -57.37M
Other Income/Expenses
$ 7.05M$ -9.73M$ 209.00K$ -4.21M$ 1.13M
Pretax Income
$ 23.22M$ -76.97M$ 9.41M$ -87.93M$ -56.24M
Net Income
$ 12.09M$ -92.93M$ 2.30M$ -87.93M$ -55.54M
Per Share Metrics
Basic EPS
$ 0.14$ -1.41$ 0.03$ -2.87$ -2.93
Diluted EPS
$ 0.05$ -1.41$ 0.03$ -2.87$ -2.93
Weighted Average Shares Outstanding
85.09M 65.83M 76.74M 30.64M 19.18M
Weighted Average Shares Outstanding (Diluted)
102.29M 65.83M 75.69M 30.64M 19.18M
Currency in USD

Gyre Therapeutics Earnings and Revenue History